A unique regulator of PPARγ expression
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Peroxisome proliferator-
1.Hauner, H.The mode of action of thiazolidinedionesDiabetes Metab. Res. Rev.18(Suppl. 2)S10-S15(2002) 2.Waki, H., Park, K.W., Mitro, N., et al.The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expressionCell Metab.5(5)357-370(2007)
Animal experiment: | Rats[4]A total of 150 male Sprague-Dawley rats (age, 10-12 weeks; weighing, 280-320 g; are used in the present study. The rats are randomly divided into three groups: Sham-operated group (sham; n=15); the TBI group (TBI; n=35) and the TBI + Harmine-treated group (Harmine; n=35). Harmine is administered immediately following TBI (i.p, 30 mg/kg per day) for up to 5 days. The sham and TBI groups receive equal volumes of 0.9% saline solution (i.p.). The rats are grouped as follows for examination of behavioral recovery: Sham, n=3; TBI, n=7; and Harmine, n=7. Following TBI, the NSS is evaluated at 1, 3 and 5 days. Each rat is assessed by an observer who is blinded to the animal treatment[4]. |
参考文献: [1]. Glennon RA, et al. Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. Drug Alcohol Depend. 2000 Aug 1;60(2):121-32. |
没有评价数据